nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—HTR6—Raloxifene—osteoporosis	0.12	0.207	CbGbCtD
Doxepin—HTR2B—Raloxifene—osteoporosis	0.107	0.185	CbGbCtD
Doxepin—CYP1A2—Estropipate—osteoporosis	0.0381	0.0655	CbGbCtD
Doxepin—CYP2C9—Estropipate—osteoporosis	0.0344	0.059	CbGbCtD
Doxepin—ABCB1—Ethinyl Estradiol—osteoporosis	0.0215	0.0369	CbGbCtD
Doxepin—CYP2C19—Cholecalciferol—osteoporosis	0.0213	0.0366	CbGbCtD
Doxepin—CYP3A4—Estropipate—osteoporosis	0.02	0.0343	CbGbCtD
Doxepin—CYP3A4—Calcitriol—osteoporosis	0.02	0.0343	CbGbCtD
Doxepin—CYP1A2—Conjugated Estrogens—osteoporosis	0.018	0.031	CbGbCtD
Doxepin—CYP2C9—Cholecalciferol—osteoporosis	0.0177	0.0304	CbGbCtD
Doxepin—CYP2C19—Estradiol—osteoporosis	0.0172	0.0295	CbGbCtD
Doxepin—CYP2D6—Cholecalciferol—osteoporosis	0.0162	0.0278	CbGbCtD
Doxepin—CYP3A4—Ergocalciferol—osteoporosis	0.016	0.0274	CbGbCtD
Doxepin—CYP1A2—Estradiol—osteoporosis	0.0158	0.0272	CbGbCtD
Doxepin—ABCB1—Conjugated Estrogens—osteoporosis	0.0158	0.0271	CbGbCtD
Doxepin—CYP2C9—Estradiol—osteoporosis	0.0143	0.0245	CbGbCtD
Doxepin—ABCB1—Estradiol—osteoporosis	0.0138	0.0238	CbGbCtD
Doxepin—CYP3A4—Raloxifene—osteoporosis	0.0133	0.0229	CbGbCtD
Doxepin—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0129	0.0221	CbGbCtD
Doxepin—CYP3A4—Cholecalciferol—osteoporosis	0.0103	0.0177	CbGbCtD
Doxepin—CYP3A4—Conjugated Estrogens—osteoporosis	0.00945	0.0162	CbGbCtD
Doxepin—CYP3A4—Estradiol—osteoporosis	0.0083	0.0143	CbGbCtD
Doxepin—Convulsion—Conjugated Estrogens—osteoporosis	0.000186	0.000601	CcSEcCtD
Doxepin—Dry mouth—Zoledronate—osteoporosis	0.000186	0.0006	CcSEcCtD
Doxepin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000186	0.000599	CcSEcCtD
Doxepin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000186	0.000598	CcSEcCtD
Doxepin—Pruritus—Alendronate—osteoporosis	0.000185	0.000597	CcSEcCtD
Doxepin—Dyspepsia—Risedronate—osteoporosis	0.000185	0.000596	CcSEcCtD
Doxepin—Eye disorder—Estradiol—osteoporosis	0.000185	0.000596	CcSEcCtD
Doxepin—Tinnitus—Estradiol—osteoporosis	0.000184	0.000594	CcSEcCtD
Doxepin—Constipation—Ethinyl Estradiol—osteoporosis	0.000184	0.000594	CcSEcCtD
Doxepin—Confusional state—Zoledronate—osteoporosis	0.000184	0.000593	CcSEcCtD
Doxepin—Hypersensitivity—Calcitriol—osteoporosis	0.000184	0.000592	CcSEcCtD
Doxepin—Flushing—Estradiol—osteoporosis	0.000184	0.000592	CcSEcCtD
Doxepin—Cardiac disorder—Estradiol—osteoporosis	0.000184	0.000592	CcSEcCtD
Doxepin—Myalgia—Conjugated Estrogens—osteoporosis	0.000183	0.00059	CcSEcCtD
Doxepin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000183	0.00059	CcSEcCtD
Doxepin—Chest pain—Conjugated Estrogens—osteoporosis	0.000183	0.00059	CcSEcCtD
Doxepin—Asthenia—Ibandronate—osteoporosis	0.000183	0.000589	CcSEcCtD
Doxepin—Anxiety—Conjugated Estrogens—osteoporosis	0.000183	0.000588	CcSEcCtD
Doxepin—Nausea—Etidronic acid—osteoporosis	0.000183	0.000588	CcSEcCtD
Doxepin—Oedema—Zoledronate—osteoporosis	0.000182	0.000588	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000182	0.000586	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000182	0.000586	CcSEcCtD
Doxepin—Diarrhoea—Estropipate—osteoporosis	0.000182	0.000586	CcSEcCtD
Doxepin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000181	0.000584	CcSEcCtD
Doxepin—Infection—Zoledronate—osteoporosis	0.000181	0.000584	CcSEcCtD
Doxepin—Fatigue—Risedronate—osteoporosis	0.000181	0.000583	CcSEcCtD
Doxepin—Insomnia—Pamidronate—osteoporosis	0.000181	0.000582	CcSEcCtD
Doxepin—Pruritus—Ibandronate—osteoporosis	0.00018	0.000581	CcSEcCtD
Doxepin—Pain—Risedronate—osteoporosis	0.00018	0.000579	CcSEcCtD
Doxepin—Constipation—Risedronate—osteoporosis	0.00018	0.000579	CcSEcCtD
Doxepin—Angiopathy—Estradiol—osteoporosis	0.00018	0.000578	CcSEcCtD
Doxepin—Shock—Zoledronate—osteoporosis	0.000179	0.000578	CcSEcCtD
Doxepin—Paraesthesia—Pamidronate—osteoporosis	0.000179	0.000578	CcSEcCtD
Doxepin—Diarrhoea—Alendronate—osteoporosis	0.000179	0.000577	CcSEcCtD
Doxepin—Asthenia—Calcitriol—osteoporosis	0.000179	0.000577	CcSEcCtD
Doxepin—Nervous system disorder—Zoledronate—osteoporosis	0.000179	0.000576	CcSEcCtD
Doxepin—Immune system disorder—Estradiol—osteoporosis	0.000179	0.000576	CcSEcCtD
Doxepin—Thrombocytopenia—Zoledronate—osteoporosis	0.000179	0.000575	CcSEcCtD
Doxepin—Mediastinal disorder—Estradiol—osteoporosis	0.000178	0.000574	CcSEcCtD
Doxepin—Dyspnoea—Pamidronate—osteoporosis	0.000178	0.000574	CcSEcCtD
Doxepin—Tachycardia—Zoledronate—osteoporosis	0.000178	0.000574	CcSEcCtD
Doxepin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000178	0.000572	CcSEcCtD
Doxepin—Chills—Estradiol—osteoporosis	0.000178	0.000572	CcSEcCtD
Doxepin—Somnolence—Pamidronate—osteoporosis	0.000178	0.000572	CcSEcCtD
Doxepin—Skin disorder—Zoledronate—osteoporosis	0.000177	0.000571	CcSEcCtD
Doxepin—Pruritus—Calcitriol—osteoporosis	0.000177	0.000569	CcSEcCtD
Doxepin—Hyperhidrosis—Zoledronate—osteoporosis	0.000176	0.000568	CcSEcCtD
Doxepin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000176	0.000568	CcSEcCtD
Doxepin—Diarrhoea—Raloxifene—osteoporosis	0.000176	0.000568	CcSEcCtD
Doxepin—Dyspepsia—Pamidronate—osteoporosis	0.000176	0.000566	CcSEcCtD
Doxepin—Dizziness—Estropipate—osteoporosis	0.000176	0.000566	CcSEcCtD
Doxepin—Oedema—Conjugated Estrogens—osteoporosis	0.000176	0.000566	CcSEcCtD
Doxepin—Alopecia—Estradiol—osteoporosis	0.000175	0.000563	CcSEcCtD
Doxepin—Infection—Conjugated Estrogens—osteoporosis	0.000174	0.000562	CcSEcCtD
Doxepin—Diarrhoea—Ibandronate—osteoporosis	0.000174	0.000562	CcSEcCtD
Doxepin—Anorexia—Zoledronate—osteoporosis	0.000174	0.00056	CcSEcCtD
Doxepin—Decreased appetite—Pamidronate—osteoporosis	0.000174	0.000559	CcSEcCtD
Doxepin—Mental disorder—Estradiol—osteoporosis	0.000173	0.000558	CcSEcCtD
Doxepin—Dizziness—Alendronate—osteoporosis	0.000173	0.000558	CcSEcCtD
Doxepin—Shock—Conjugated Estrogens—osteoporosis	0.000173	0.000557	CcSEcCtD
Doxepin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000172	0.000555	CcSEcCtD
Doxepin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000172	0.000555	CcSEcCtD
Doxepin—Erythema—Estradiol—osteoporosis	0.000172	0.000555	CcSEcCtD
Doxepin—Malnutrition—Estradiol—osteoporosis	0.000172	0.000555	CcSEcCtD
Doxepin—Fatigue—Pamidronate—osteoporosis	0.000172	0.000555	CcSEcCtD
Doxepin—Gastrointestinal pain—Risedronate—osteoporosis	0.000172	0.000553	CcSEcCtD
Doxepin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000171	0.000552	CcSEcCtD
Doxepin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000171	0.000551	CcSEcCtD
Doxepin—Pain—Pamidronate—osteoporosis	0.000171	0.00055	CcSEcCtD
Doxepin—Constipation—Pamidronate—osteoporosis	0.000171	0.00055	CcSEcCtD
Doxepin—Diarrhoea—Calcitriol—osteoporosis	0.000171	0.00055	CcSEcCtD
Doxepin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000171	0.00055	CcSEcCtD
Doxepin—Hypotension—Zoledronate—osteoporosis	0.00017	0.000549	CcSEcCtD
Doxepin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00017	0.000549	CcSEcCtD
Doxepin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00017	0.000549	CcSEcCtD
Doxepin—Dizziness—Raloxifene—osteoporosis	0.00017	0.000549	CcSEcCtD
Doxepin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00017	0.000547	CcSEcCtD
Doxepin—Flatulence—Estradiol—osteoporosis	0.00017	0.000547	CcSEcCtD
Doxepin—Tension—Estradiol—osteoporosis	0.000169	0.000545	CcSEcCtD
Doxepin—Vomiting—Estropipate—osteoporosis	0.000169	0.000544	CcSEcCtD
Doxepin—Dysgeusia—Estradiol—osteoporosis	0.000169	0.000543	CcSEcCtD
Doxepin—Dizziness—Ibandronate—osteoporosis	0.000169	0.000543	CcSEcCtD
Doxepin—Rash—Estropipate—osteoporosis	0.000168	0.00054	CcSEcCtD
Doxepin—Dermatitis—Estropipate—osteoporosis	0.000167	0.000539	CcSEcCtD
Doxepin—Anorexia—Conjugated Estrogens—osteoporosis	0.000167	0.000539	CcSEcCtD
Doxepin—Nervousness—Estradiol—osteoporosis	0.000167	0.000539	CcSEcCtD
Doxepin—Urticaria—Risedronate—osteoporosis	0.000167	0.000538	CcSEcCtD
Doxepin—Back pain—Estradiol—osteoporosis	0.000167	0.000537	CcSEcCtD
Doxepin—Headache—Estropipate—osteoporosis	0.000167	0.000536	CcSEcCtD
Doxepin—Vomiting—Alendronate—osteoporosis	0.000166	0.000536	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000166	0.000535	CcSEcCtD
Doxepin—Abdominal pain—Risedronate—osteoporosis	0.000166	0.000535	CcSEcCtD
Doxepin—Body temperature increased—Risedronate—osteoporosis	0.000166	0.000535	CcSEcCtD
Doxepin—Muscle spasms—Estradiol—osteoporosis	0.000166	0.000533	CcSEcCtD
Doxepin—Rash—Alendronate—osteoporosis	0.000165	0.000532	CcSEcCtD
Doxepin—Insomnia—Zoledronate—osteoporosis	0.000165	0.000532	CcSEcCtD
Doxepin—Dermatitis—Alendronate—osteoporosis	0.000165	0.000531	CcSEcCtD
Doxepin—Feeling abnormal—Pamidronate—osteoporosis	0.000165	0.00053	CcSEcCtD
Doxepin—Hypotension—Conjugated Estrogens—osteoporosis	0.000164	0.000529	CcSEcCtD
Doxepin—Headache—Alendronate—osteoporosis	0.000164	0.000528	CcSEcCtD
Doxepin—Paraesthesia—Zoledronate—osteoporosis	0.000164	0.000528	CcSEcCtD
Doxepin—Vomiting—Raloxifene—osteoporosis	0.000164	0.000527	CcSEcCtD
Doxepin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000163	0.000526	CcSEcCtD
Doxepin—Dyspnoea—Zoledronate—osteoporosis	0.000163	0.000524	CcSEcCtD
Doxepin—Rash—Raloxifene—osteoporosis	0.000162	0.000523	CcSEcCtD
Doxepin—Dermatitis—Raloxifene—osteoporosis	0.000162	0.000523	CcSEcCtD
Doxepin—Somnolence—Zoledronate—osteoporosis	0.000162	0.000522	CcSEcCtD
Doxepin—Vomiting—Ibandronate—osteoporosis	0.000162	0.000522	CcSEcCtD
Doxepin—Tremor—Estradiol—osteoporosis	0.000161	0.00052	CcSEcCtD
Doxepin—Headache—Raloxifene—osteoporosis	0.000161	0.00052	CcSEcCtD
Doxepin—Rash—Ibandronate—osteoporosis	0.000161	0.000518	CcSEcCtD
Doxepin—Dermatitis—Ibandronate—osteoporosis	0.000161	0.000517	CcSEcCtD
Doxepin—Dyspepsia—Zoledronate—osteoporosis	0.000161	0.000517	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00016	0.000516	CcSEcCtD
Doxepin—Ill-defined disorder—Estradiol—osteoporosis	0.00016	0.000515	CcSEcCtD
Doxepin—Headache—Ibandronate—osteoporosis	0.00016	0.000514	CcSEcCtD
Doxepin—Insomnia—Conjugated Estrogens—osteoporosis	0.000159	0.000512	CcSEcCtD
Doxepin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000159	0.000511	CcSEcCtD
Doxepin—Vomiting—Calcitriol—osteoporosis	0.000159	0.000511	CcSEcCtD
Doxepin—Decreased appetite—Zoledronate—osteoporosis	0.000159	0.000511	CcSEcCtD
Doxepin—Agitation—Estradiol—osteoporosis	0.000158	0.00051	CcSEcCtD
Doxepin—Nausea—Estropipate—osteoporosis	0.000158	0.000509	CcSEcCtD
Doxepin—Body temperature increased—Pamidronate—osteoporosis	0.000158	0.000509	CcSEcCtD
Doxepin—Abdominal pain—Pamidronate—osteoporosis	0.000158	0.000509	CcSEcCtD
Doxepin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000158	0.000508	CcSEcCtD
Doxepin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000157	0.000507	CcSEcCtD
Doxepin—Rash—Calcitriol—osteoporosis	0.000157	0.000507	CcSEcCtD
Doxepin—Fatigue—Zoledronate—osteoporosis	0.000157	0.000507	CcSEcCtD
Doxepin—Dermatitis—Calcitriol—osteoporosis	0.000157	0.000506	CcSEcCtD
Doxepin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000157	0.000504	CcSEcCtD
Doxepin—Headache—Calcitriol—osteoporosis	0.000156	0.000504	CcSEcCtD
Doxepin—Somnolence—Conjugated Estrogens—osteoporosis	0.000156	0.000503	CcSEcCtD
Doxepin—Pain—Zoledronate—osteoporosis	0.000156	0.000503	CcSEcCtD
Doxepin—Constipation—Zoledronate—osteoporosis	0.000156	0.000503	CcSEcCtD
Doxepin—Nausea—Alendronate—osteoporosis	0.000156	0.000501	CcSEcCtD
Doxepin—Malaise—Estradiol—osteoporosis	0.000155	0.0005	CcSEcCtD
Doxepin—Hypersensitivity—Risedronate—osteoporosis	0.000155	0.000499	CcSEcCtD
Doxepin—Vertigo—Estradiol—osteoporosis	0.000155	0.000499	CcSEcCtD
Doxepin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000155	0.000498	CcSEcCtD
Doxepin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000155	0.000498	CcSEcCtD
Doxepin—Syncope—Estradiol—osteoporosis	0.000154	0.000498	CcSEcCtD
Doxepin—Nausea—Raloxifene—osteoporosis	0.000153	0.000493	CcSEcCtD
Doxepin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000153	0.000492	CcSEcCtD
Doxepin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000152	0.000491	CcSEcCtD
Doxepin—Palpitations—Estradiol—osteoporosis	0.000152	0.00049	CcSEcCtD
Doxepin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000152	0.000489	CcSEcCtD
Doxepin—Fatigue—Conjugated Estrogens—osteoporosis	0.000151	0.000488	CcSEcCtD
Doxepin—Nausea—Ibandronate—osteoporosis	0.000151	0.000488	CcSEcCtD
Doxepin—Loss of consciousness—Estradiol—osteoporosis	0.000151	0.000488	CcSEcCtD
Doxepin—Asthenia—Risedronate—osteoporosis	0.000151	0.000486	CcSEcCtD
Doxepin—Feeling abnormal—Zoledronate—osteoporosis	0.00015	0.000484	CcSEcCtD
Doxepin—Cough—Estradiol—osteoporosis	0.00015	0.000484	CcSEcCtD
Doxepin—Constipation—Conjugated Estrogens—osteoporosis	0.00015	0.000484	CcSEcCtD
Doxepin—Pain—Conjugated Estrogens—osteoporosis	0.00015	0.000484	CcSEcCtD
Doxepin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000149	0.000481	CcSEcCtD
Doxepin—Hypertension—Estradiol—osteoporosis	0.000149	0.000479	CcSEcCtD
Doxepin—Pruritus—Risedronate—osteoporosis	0.000149	0.000479	CcSEcCtD
Doxepin—Nausea—Calcitriol—osteoporosis	0.000148	0.000477	CcSEcCtD
Doxepin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000147	0.000475	CcSEcCtD
Doxepin—Hypersensitivity—Pamidronate—osteoporosis	0.000147	0.000474	CcSEcCtD
Doxepin—Chest pain—Estradiol—osteoporosis	0.000147	0.000472	CcSEcCtD
Doxepin—Myalgia—Estradiol—osteoporosis	0.000147	0.000472	CcSEcCtD
Doxepin—Arthralgia—Estradiol—osteoporosis	0.000147	0.000472	CcSEcCtD
Doxepin—Anxiety—Estradiol—osteoporosis	0.000146	0.000471	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000146	0.000469	CcSEcCtD
Doxepin—Urticaria—Zoledronate—osteoporosis	0.000145	0.000467	CcSEcCtD
Doxepin—Discomfort—Estradiol—osteoporosis	0.000145	0.000467	CcSEcCtD
Doxepin—Abdominal pain—Zoledronate—osteoporosis	0.000144	0.000465	CcSEcCtD
Doxepin—Body temperature increased—Zoledronate—osteoporosis	0.000144	0.000465	CcSEcCtD
Doxepin—Diarrhoea—Risedronate—osteoporosis	0.000144	0.000463	CcSEcCtD
Doxepin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000144	0.000463	CcSEcCtD
Doxepin—Dry mouth—Estradiol—osteoporosis	0.000143	0.000462	CcSEcCtD
Doxepin—Asthenia—Pamidronate—osteoporosis	0.000143	0.000462	CcSEcCtD
Doxepin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000142	0.000459	CcSEcCtD
Doxepin—Confusional state—Estradiol—osteoporosis	0.000142	0.000457	CcSEcCtD
Doxepin—Pruritus—Pamidronate—osteoporosis	0.000141	0.000455	CcSEcCtD
Doxepin—Oedema—Estradiol—osteoporosis	0.000141	0.000453	CcSEcCtD
Doxepin—Infection—Estradiol—osteoporosis	0.00014	0.00045	CcSEcCtD
Doxepin—Urticaria—Conjugated Estrogens—osteoporosis	0.00014	0.00045	CcSEcCtD
Doxepin—Dizziness—Risedronate—osteoporosis	0.000139	0.000448	CcSEcCtD
Doxepin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000139	0.000447	CcSEcCtD
Doxepin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000139	0.000447	CcSEcCtD
Doxepin—Shock—Estradiol—osteoporosis	0.000138	0.000446	CcSEcCtD
Doxepin—Nervous system disorder—Estradiol—osteoporosis	0.000138	0.000444	CcSEcCtD
Doxepin—Tachycardia—Estradiol—osteoporosis	0.000137	0.000442	CcSEcCtD
Doxepin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000137	0.000441	CcSEcCtD
Doxepin—Diarrhoea—Pamidronate—osteoporosis	0.000137	0.00044	CcSEcCtD
Doxepin—Skin disorder—Estradiol—osteoporosis	0.000137	0.00044	CcSEcCtD
Doxepin—Hyperhidrosis—Estradiol—osteoporosis	0.000136	0.000438	CcSEcCtD
Doxepin—Rash—Ethinyl Estradiol—osteoporosis	0.000136	0.000438	CcSEcCtD
Doxepin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000136	0.000437	CcSEcCtD
Doxepin—Headache—Ethinyl Estradiol—osteoporosis	0.000135	0.000435	CcSEcCtD
Doxepin—Hypersensitivity—Zoledronate—osteoporosis	0.000134	0.000433	CcSEcCtD
Doxepin—Vomiting—Risedronate—osteoporosis	0.000134	0.00043	CcSEcCtD
Doxepin—Rash—Risedronate—osteoporosis	0.000132	0.000427	CcSEcCtD
Doxepin—Dermatitis—Risedronate—osteoporosis	0.000132	0.000426	CcSEcCtD
Doxepin—Dizziness—Pamidronate—osteoporosis	0.000132	0.000425	CcSEcCtD
Doxepin—Headache—Risedronate—osteoporosis	0.000132	0.000424	CcSEcCtD
Doxepin—Asthenia—Zoledronate—osteoporosis	0.000131	0.000422	CcSEcCtD
Doxepin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000129	0.000417	CcSEcCtD
Doxepin—Pruritus—Zoledronate—osteoporosis	0.000129	0.000416	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000128	0.000413	CcSEcCtD
Doxepin—Nausea—Ethinyl Estradiol—osteoporosis	0.000128	0.000412	CcSEcCtD
Doxepin—Insomnia—Estradiol—osteoporosis	0.000127	0.00041	CcSEcCtD
Doxepin—Vomiting—Pamidronate—osteoporosis	0.000127	0.000409	CcSEcCtD
Doxepin—Paraesthesia—Estradiol—osteoporosis	0.000126	0.000407	CcSEcCtD
Doxepin—Asthenia—Conjugated Estrogens—osteoporosis	0.000126	0.000406	CcSEcCtD
Doxepin—Rash—Pamidronate—osteoporosis	0.000126	0.000406	CcSEcCtD
Doxepin—Dermatitis—Pamidronate—osteoporosis	0.000126	0.000405	CcSEcCtD
Doxepin—Dyspnoea—Estradiol—osteoporosis	0.000125	0.000404	CcSEcCtD
Doxepin—Headache—Pamidronate—osteoporosis	0.000125	0.000403	CcSEcCtD
Doxepin—Somnolence—Estradiol—osteoporosis	0.000125	0.000403	CcSEcCtD
Doxepin—Diarrhoea—Zoledronate—osteoporosis	0.000125	0.000402	CcSEcCtD
Doxepin—Nausea—Risedronate—osteoporosis	0.000125	0.000402	CcSEcCtD
Doxepin—Pruritus—Conjugated Estrogens—osteoporosis	0.000124	0.0004	CcSEcCtD
Doxepin—Dyspepsia—Estradiol—osteoporosis	0.000124	0.000399	CcSEcCtD
Doxepin—Decreased appetite—Estradiol—osteoporosis	0.000122	0.000394	CcSEcCtD
Doxepin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000121	0.000391	CcSEcCtD
Doxepin—Fatigue—Estradiol—osteoporosis	0.000121	0.00039	CcSEcCtD
Doxepin—Dizziness—Zoledronate—osteoporosis	0.000121	0.000389	CcSEcCtD
Doxepin—Pain—Estradiol—osteoporosis	0.00012	0.000387	CcSEcCtD
Doxepin—Constipation—Estradiol—osteoporosis	0.00012	0.000387	CcSEcCtD
Doxepin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00012	0.000387	CcSEcCtD
Doxepin—Nausea—Pamidronate—osteoporosis	0.000119	0.000382	CcSEcCtD
Doxepin—Dizziness—Conjugated Estrogens—osteoporosis	0.000116	0.000374	CcSEcCtD
Doxepin—Vomiting—Zoledronate—osteoporosis	0.000116	0.000374	CcSEcCtD
Doxepin—Feeling abnormal—Estradiol—osteoporosis	0.000116	0.000373	CcSEcCtD
Doxepin—Rash—Zoledronate—osteoporosis	0.000115	0.000371	CcSEcCtD
Doxepin—Gastrointestinal pain—Estradiol—osteoporosis	0.000115	0.00037	CcSEcCtD
Doxepin—Dermatitis—Zoledronate—osteoporosis	0.000115	0.00037	CcSEcCtD
Doxepin—Headache—Zoledronate—osteoporosis	0.000114	0.000368	CcSEcCtD
Doxepin—Vomiting—Conjugated Estrogens—osteoporosis	0.000112	0.00036	CcSEcCtD
Doxepin—Urticaria—Estradiol—osteoporosis	0.000112	0.00036	CcSEcCtD
Doxepin—Abdominal pain—Estradiol—osteoporosis	0.000111	0.000358	CcSEcCtD
Doxepin—Body temperature increased—Estradiol—osteoporosis	0.000111	0.000358	CcSEcCtD
Doxepin—Rash—Conjugated Estrogens—osteoporosis	0.000111	0.000357	CcSEcCtD
Doxepin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000111	0.000356	CcSEcCtD
Doxepin—Headache—Conjugated Estrogens—osteoporosis	0.00011	0.000354	CcSEcCtD
Doxepin—Nausea—Zoledronate—osteoporosis	0.000108	0.000349	CcSEcCtD
Doxepin—Nausea—Conjugated Estrogens—osteoporosis	0.000104	0.000336	CcSEcCtD
Doxepin—Hypersensitivity—Estradiol—osteoporosis	0.000104	0.000334	CcSEcCtD
Doxepin—Asthenia—Estradiol—osteoporosis	0.000101	0.000325	CcSEcCtD
Doxepin—Pruritus—Estradiol—osteoporosis	9.95e-05	0.00032	CcSEcCtD
Doxepin—Diarrhoea—Estradiol—osteoporosis	9.62e-05	0.00031	CcSEcCtD
Doxepin—Dizziness—Estradiol—osteoporosis	9.3e-05	0.000299	CcSEcCtD
Doxepin—Vomiting—Estradiol—osteoporosis	8.94e-05	0.000288	CcSEcCtD
Doxepin—Rash—Estradiol—osteoporosis	8.86e-05	0.000286	CcSEcCtD
Doxepin—Dermatitis—Estradiol—osteoporosis	8.86e-05	0.000285	CcSEcCtD
Doxepin—Headache—Estradiol—osteoporosis	8.81e-05	0.000284	CcSEcCtD
Doxepin—Nausea—Estradiol—osteoporosis	8.35e-05	0.000269	CcSEcCtD
Doxepin—ADRA2C—Signaling Pathways—SPP1—osteoporosis	1.03e-05	9.54e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.02e-05	9.51e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IRS1—osteoporosis	1.02e-05	9.5e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ENO1—osteoporosis	1.02e-05	9.48e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PSMA2—osteoporosis	1.01e-05	9.42e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PSMA5—osteoporosis	1.01e-05	9.42e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—SPP1—osteoporosis	1.01e-05	9.39e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PSMA2—osteoporosis	1e-05	9.34e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PSMA5—osteoporosis	1e-05	9.34e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6R—osteoporosis	1e-05	9.32e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ACP5—osteoporosis	9.94e-06	9.25e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—POMC—osteoporosis	9.94e-06	9.25e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IRS2—osteoporosis	9.93e-06	9.24e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IGF1—osteoporosis	9.88e-06	9.19e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—POMC—osteoporosis	9.83e-06	9.15e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—LEP—osteoporosis	9.72e-06	9.04e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6R—osteoporosis	9.69e-06	9.02e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ADCY5—osteoporosis	9.62e-06	8.95e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IRS1—osteoporosis	9.6e-06	8.93e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6R—osteoporosis	9.59e-06	8.93e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IRS2—osteoporosis	9.59e-06	8.92e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IGF1—osteoporosis	9.56e-06	8.89e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IRS2—osteoporosis	9.54e-06	8.87e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—MTHFR—osteoporosis	9.47e-06	8.81e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ADCY5—osteoporosis	9.46e-06	8.81e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IGF1—osteoporosis	9.46e-06	8.8e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ADCY5—osteoporosis	9.44e-06	8.79e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ADCY5—osteoporosis	9.41e-06	8.76e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.39e-06	8.74e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ADCY5—osteoporosis	9.38e-06	8.73e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—LEP—osteoporosis	9.38e-06	8.73e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—LEP—osteoporosis	9.33e-06	8.68e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—POMC—osteoporosis	9.33e-06	8.68e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SPP1—osteoporosis	9.31e-06	8.66e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ADCY5—osteoporosis	9.29e-06	8.65e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—ESR1—osteoporosis	9.28e-06	8.63e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IRS2—osteoporosis	9.28e-06	8.63e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	9.27e-06	8.62e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—POMC—osteoporosis	9.25e-06	8.6e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—TPI1—osteoporosis	9.24e-06	8.6e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SPP1—osteoporosis	9.16e-06	8.52e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SPP1—osteoporosis	9.14e-06	8.5e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IRS2—osteoporosis	9.13e-06	8.49e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SPP1—osteoporosis	9.11e-06	8.47e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SPP1—osteoporosis	9.08e-06	8.45e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—LEP—osteoporosis	9.08e-06	8.45e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6R—osteoporosis	9.02e-06	8.39e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SPP1—osteoporosis	8.99e-06	8.36e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SPP1—osteoporosis	8.97e-06	8.34e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—ESR1—osteoporosis	8.96e-06	8.33e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—LEP—osteoporosis	8.93e-06	8.31e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CYP19A1—osteoporosis	8.93e-06	8.31e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—ESR1—osteoporosis	8.91e-06	8.29e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IGF1—osteoporosis	8.89e-06	8.27e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CYP19A1—osteoporosis	8.72e-06	8.11e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ENO1—osteoporosis	8.7e-06	8.1e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—P4HB—osteoporosis	8.69e-06	8.09e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IRS1—osteoporosis	8.67e-06	8.07e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—ESR1—osteoporosis	8.67e-06	8.06e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	8.61e-06	8.01e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PSMA2—osteoporosis	8.58e-06	7.98e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PSMA5—osteoporosis	8.58e-06	7.98e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GAPDH—osteoporosis	8.53e-06	7.94e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—ESR1—osteoporosis	8.53e-06	7.94e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IRS2—osteoporosis	8.42e-06	7.83e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IRS1—osteoporosis	8.37e-06	7.79e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—POMC—osteoporosis	8.35e-06	7.77e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SPP1—osteoporosis	8.33e-06	7.75e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IRS1—osteoporosis	8.33e-06	7.75e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—RAP1A—osteoporosis	8.31e-06	7.73e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IRS2—osteoporosis	8.28e-06	7.7e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IRS2—osteoporosis	8.26e-06	7.69e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—POMC—osteoporosis	8.25e-06	7.68e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IRS2—osteoporosis	8.24e-06	7.66e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—LEP—osteoporosis	8.24e-06	7.66e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.21e-06	7.64e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IRS2—osteoporosis	8.21e-06	7.64e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MYC—osteoporosis	8.21e-06	7.63e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TGFB1—osteoporosis	8.19e-06	7.62e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6R—osteoporosis	8.14e-06	7.58e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CYP19A1—osteoporosis	8.14e-06	7.58e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IRS2—osteoporosis	8.13e-06	7.56e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IRS2—osteoporosis	8.11e-06	7.54e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—LEP—osteoporosis	8.1e-06	7.54e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IRS1—osteoporosis	8.1e-06	7.53e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—LEP—osteoporosis	8.09e-06	7.52e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—LEP—osteoporosis	8.06e-06	7.5e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—POMC—osteoporosis	8.06e-06	7.5e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—LEP—osteoporosis	8.03e-06	7.48e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IGF1—osteoporosis	8.03e-06	7.47e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—POMC—osteoporosis	8.02e-06	7.46e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—IL6—osteoporosis	8.01e-06	7.45e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IRS1—osteoporosis	7.97e-06	7.41e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—LEP—osteoporosis	7.96e-06	7.4e-05	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—IL6—osteoporosis	7.95e-06	7.4e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—LEP—osteoporosis	7.94e-06	7.38e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ESR1—osteoporosis	7.86e-06	7.32e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6R—osteoporosis	7.86e-06	7.31e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6R—osteoporosis	7.82e-06	7.28e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—POMC—osteoporosis	7.8e-06	7.25e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IGF1—osteoporosis	7.75e-06	7.21e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ESR1—osteoporosis	7.74e-06	7.2e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ESR1—osteoporosis	7.72e-06	7.18e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IGF1—osteoporosis	7.71e-06	7.17e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ESR1—osteoporosis	7.7e-06	7.16e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—POMC—osteoporosis	7.67e-06	7.14e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ESR1—osteoporosis	7.67e-06	7.14e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6R—osteoporosis	7.61e-06	7.08e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ESR1—osteoporosis	7.6e-06	7.07e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ESR1—osteoporosis	7.58e-06	7.05e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—POMC—osteoporosis	7.57e-06	7.05e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—IL6—osteoporosis	7.55e-06	7.03e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IRS2—osteoporosis	7.53e-06	7.01e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IGF1—osteoporosis	7.5e-06	6.98e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6R—osteoporosis	7.49e-06	6.97e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IGF1—osteoporosis	7.38e-06	6.87e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—LEP—osteoporosis	7.37e-06	6.86e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IRS1—osteoporosis	7.35e-06	6.84e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—IL6—osteoporosis	7.31e-06	6.8e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ADCY5—osteoporosis	7.3e-06	6.79e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—GPX1—osteoporosis	7.27e-06	6.76e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—IL6—osteoporosis	7.23e-06	6.73e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IRS1—osteoporosis	7.23e-06	6.73e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IRS1—osteoporosis	7.21e-06	6.71e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IRS1—osteoporosis	7.19e-06	6.69e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IRS1—osteoporosis	7.17e-06	6.67e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ADCY5—osteoporosis	7.12e-06	6.63e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IRS1—osteoporosis	7.1e-06	6.6e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GPX1—osteoporosis	7.1e-06	6.6e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IRS1—osteoporosis	7.08e-06	6.59e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—POMC—osteoporosis	7.08e-06	6.58e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ESR1—osteoporosis	7.04e-06	6.55e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—POMC—osteoporosis	6.96e-06	6.48e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CYP19A1—osteoporosis	6.96e-06	6.47e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—POMC—osteoporosis	6.95e-06	6.46e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—POMC—osteoporosis	6.92e-06	6.44e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—POMC—osteoporosis	6.9e-06	6.42e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6R—osteoporosis	6.9e-06	6.42e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—POMC—osteoporosis	6.84e-06	6.36e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—POMC—osteoporosis	6.82e-06	6.34e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IGF1—osteoporosis	6.81e-06	6.33e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—IL6—osteoporosis	6.8e-06	6.33e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6R—osteoporosis	6.79e-06	6.32e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6R—osteoporosis	6.78e-06	6.3e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6R—osteoporosis	6.75e-06	6.28e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6R—osteoporosis	6.73e-06	6.26e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ENO1—osteoporosis	6.72e-06	6.25e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ADCY5—osteoporosis	6.71e-06	6.24e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—MTHFR—osteoporosis	6.71e-06	6.24e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IGF1—osteoporosis	6.7e-06	6.23e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GPX1—osteoporosis	6.69e-06	6.22e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IGF1—osteoporosis	6.68e-06	6.22e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6R—osteoporosis	6.67e-06	6.2e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IGF1—osteoporosis	6.66e-06	6.2e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ADCY5—osteoporosis	6.65e-06	6.19e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6R—osteoporosis	6.65e-06	6.19e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IGF1—osteoporosis	6.64e-06	6.18e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GPX1—osteoporosis	6.63e-06	6.17e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PSMA2—osteoporosis	6.62e-06	6.16e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PSMA5—osteoporosis	6.62e-06	6.16e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IRS1—osteoporosis	6.58e-06	6.12e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IGF1—osteoporosis	6.57e-06	6.12e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IGF1—osteoporosis	6.56e-06	6.1e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—MTHFR—osteoporosis	6.55e-06	6.09e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—POMC—osteoporosis	6.33e-06	5.89e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MYC—osteoporosis	6.29e-06	5.86e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TGFB1—osteoporosis	6.28e-06	5.84e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6R—osteoporosis	6.18e-06	5.75e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—MTHFR—osteoporosis	6.17e-06	5.74e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IL6—osteoporosis	6.17e-06	5.74e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—IL6—osteoporosis	6.14e-06	5.71e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—MTHFR—osteoporosis	6.12e-06	5.69e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IGF1—osteoporosis	6.09e-06	5.67e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MYC—osteoporosis	5.94e-06	5.52e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—IL6—osteoporosis	5.93e-06	5.52e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TGFB1—osteoporosis	5.92e-06	5.51e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—IL6—osteoporosis	5.9e-06	5.49e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MYC—osteoporosis	5.74e-06	5.34e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL6—osteoporosis	5.74e-06	5.34e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TGFB1—osteoporosis	5.73e-06	5.33e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MYC—osteoporosis	5.68e-06	5.29e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ADCY5—osteoporosis	5.68e-06	5.29e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TGFB1—osteoporosis	5.67e-06	5.28e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GPX1—osteoporosis	5.67e-06	5.27e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—osteoporosis	5.65e-06	5.25e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.37e-06	5e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—POMC—osteoporosis	5.37e-06	4.99e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MYC—osteoporosis	5.35e-06	4.97e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	5.33e-06	4.96e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—POMC—osteoporosis	5.24e-06	4.87e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MTHFR—osteoporosis	5.23e-06	4.86e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—osteoporosis	5.2e-06	4.84e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—osteoporosis	5.12e-06	4.76e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—osteoporosis	5.11e-06	4.75e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—osteoporosis	5.09e-06	4.74e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—osteoporosis	5.08e-06	4.72e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—osteoporosis	5.03e-06	4.68e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—osteoporosis	5.01e-06	4.67e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—POMC—osteoporosis	4.94e-06	4.59e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—POMC—osteoporosis	4.89e-06	4.55e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MYC—osteoporosis	4.83e-06	4.49e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	4.81e-06	4.48e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—osteoporosis	4.73e-06	4.4e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—osteoporosis	4.66e-06	4.33e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—osteoporosis	4.66e-06	4.33e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—osteoporosis	4.65e-06	4.32e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—osteoporosis	4.63e-06	4.31e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—osteoporosis	4.62e-06	4.3e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—osteoporosis	4.51e-06	4.19e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	4.5e-06	4.18e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—osteoporosis	4.46e-06	4.15e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—osteoporosis	4.44e-06	4.13e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	4.43e-06	4.12e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ADCY5—osteoporosis	4.39e-06	4.08e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GPX1—osteoporosis	4.37e-06	4.07e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—osteoporosis	4.32e-06	4.02e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—osteoporosis	4.27e-06	3.98e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—POMC—osteoporosis	4.18e-06	3.89e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—osteoporosis	4.09e-06	3.81e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—osteoporosis	4.08e-06	3.8e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—osteoporosis	4.04e-06	3.75e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—osteoporosis	4.02e-06	3.74e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—osteoporosis	4.02e-06	3.74e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—osteoporosis	4.02e-06	3.74e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—osteoporosis	4.01e-06	3.74e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—osteoporosis	4.01e-06	3.73e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—osteoporosis	4e-06	3.72e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—osteoporosis	3.99e-06	3.72e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—osteoporosis	3.99e-06	3.71e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—osteoporosis	3.98e-06	3.7e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—osteoporosis	3.95e-06	3.68e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—osteoporosis	3.94e-06	3.67e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—osteoporosis	3.94e-06	3.67e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	3.93e-06	3.66e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—osteoporosis	3.66e-06	3.41e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	3.65e-06	3.4e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—osteoporosis	3.63e-06	3.37e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—osteoporosis	3.5e-06	3.26e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—osteoporosis	3.48e-06	3.24e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—osteoporosis	3.39e-06	3.15e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—osteoporosis	3.33e-06	3.1e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—POMC—osteoporosis	3.23e-06	3e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—osteoporosis	3.07e-06	2.86e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—osteoporosis	3.03e-06	2.81e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—osteoporosis	3.02e-06	2.81e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—osteoporosis	3.01e-06	2.8e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—osteoporosis	3e-06	2.79e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—osteoporosis	2.97e-06	2.76e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—osteoporosis	2.96e-06	2.76e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—osteoporosis	2.75e-06	2.56e-05	CbGpPWpGaD
